1. Home
  2. TITN vs ALT Comparison

TITN vs ALT Comparison

Compare TITN & ALT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Titan Machinery Inc.

TITN

Titan Machinery Inc.

HOLD

Current Price

$15.81

Market Cap

395.9M

ML Signal

HOLD

Logo Altimmune Inc.

ALT

Altimmune Inc.

HOLD

Current Price

$5.70

Market Cap

501.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
TITN
ALT
Founded
1980
1997
Country
United States
United States
Employees
N/A
N/A
Industry
Other Specialty Stores
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
395.9M
501.9M
IPO Year
2007
N/A

Fundamental Metrics

Financial Performance
Metric
TITN
ALT
Price
$15.81
$5.70
Analyst Decision
Hold
Strong Buy
Analyst Count
4
7
Target Price
$21.50
$16.33
AVG Volume (30 Days)
211.7K
3.3M
Earning Date
11-25-2025
11-06-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$2,545,195,000.00
$20,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$12.50
$2.90
52 Week High
$23.41
$9.95

Technical Indicators

Market Signals
Indicator
TITN
ALT
Relative Strength Index (RSI) 44.11 72.03
Support Level $16.51 $4.70
Resistance Level $20.39 $5.46
Average True Range (ATR) 0.99 0.37
MACD -0.10 0.06
Stochastic Oscillator 15.45 94.24

Price Performance

Historical Comparison
TITN
ALT

About TITN Titan Machinery Inc.

Titan Machinery Inc owns and operates a network of full-service agricultural and construction equipment stores. The company sells and repairs agricultural equipment, including machinery and attachments for large-scale farming and home and gardening purposes, as well as construction equipment. It operates through the following segments: The Agriculture segment sells, services, and rents machinery and related parts and attachments, for uses ranging from large-scale farming to home and garden use, The construction segment sells, services, and rents machinery, and related parts and attachments, for uses ranging from heavy construction to light industrial machinery use, and the Europe and Australia segments.

About ALT Altimmune Inc.

Altimmune Inc is a clinical-stage biopharmaceutical company focused on developing treatments for obesity, metabolic diseases, and liver diseases. Its product candidate, pemvidutide (formerly known as ALT-801), is a novel, investigational, peptide-based GLP-1/glucagon dual receptor agonist. Pemvidutide is currently in clinical development for obesity and metabolic-associated steatohepatitis (MASH). The company also plans to pursue additional indications for pemvidutide that leverage the differentiated clinical profile of pemvidutide.

Share on Social Networks: